Contributors

Contributors Irish geneticist W.H. Irwin McLean has devoted the better part of the past two decades to studying rare, single-gene skin disorders. His work on these diseases led him to filaggrin, “a really weird gene,” that plays a role in the development of dry, flaky skin. Surprisingly, mutations in that same gene are also involved in complex allergic disorders such as atopic eczema and asthma. McLean is a professor of human genetics at the Univer

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Irish geneticist W.H. Irwin McLean has devoted the better part of the past two decades to studying rare, single-gene skin disorders. His work on these diseases led him to filaggrin, “a really weird gene,” that plays a role in the development of dry, flaky skin. Surprisingly, mutations in that same gene are also involved in complex allergic disorders such as atopic eczema and asthma. McLean is a professor of human genetics at the University of Dundee, UK, and has degrees in microbiology and biochemistry from Queen’s University Belfast.

A native Londoner, Richard Smith has worn many hats throughout his career: doctor, editor, businessman, passionate advocate of open-access publishing, and television personality—to name a few. He is currently the director of the UnitedHealth Chronic Disease Initiative, which strives to combat illnesses such as diabetes, cardiovascular disease, chronic obstructive pulmonary disease, and cancer in the developing world. “Eighty percent of those deaths ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies